LAST NEWS
14 November 2017
Information relative to BSAR C
After closing of the trading day on October 31, 2017, Europlasma granted 152,405,521 warrants (BSAR C) for the benefit of the company’s shareholders on the basis of one BSAR C for one…
7 November 2017
Number of shares and voting rights as at 31/10/2017
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st October. Read the press release
31 October 2017
Free allocation of stock warrants
Following the approval by the shareholders of the 3rd resolution at the Shareholders' Meeting on 26/10/2017, the company issued redeemable share warrants (BSAR C). Read the Euronext notice
26 October 2017
General Meeting of shareholders on 26/10/2017
Approval of all Resolutions On October 26, 2017 (by 2nd call), under the chairmanship of Pierre Catlin, the Extraordinary General Meeting of the Company gathered its shareholders…
24 October 2017
2017 half-year Results as at 30 June 2017
Europlasma today announces its results for the six months ended June 30, 2017, which were subject to a limited review by Auditors and were approved by the Board of Directors on October 24,…
10 October 2017
General Meeting of Shareholders, new call
On 10 October 2017, under the chairmanship of Pierre Catlin, the Extraordinary General Meeting of the Company gathered shareholders representing 30,253,122 shares (present, represented or…
10 October 2017
Number of shares and voting rights as at 30/09/2017
Europlasma declares the number of voting rights and shares comprising its share capital as at 30 September. Read the release
26 September 2017
Review of the 2014-2017 Strategy and growth outlook
After 3 years of efforts, 2017 saw the industrial and commercial achievements of innovative application of the plasma torch in various projects that fully meet current and future…